1. Jung UJ, Choi MS. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci 2014;15:6184-223.
[CROSSREF] [PUBMED] [PMC]
2. Groneberg DA, Franke K, Klingelhofer D, Schwarzer M, Ohlendorf D. Density equalizing mapping of obesity: analysis of a global epidemic. Z Gastroenterol 2015;53:553-61.
[CROSSREF] [PUBMED]
3. Newell-Fugate AE. The role of sex steroids in white adipose tissue adipocyte function. Reproduction 2017;153:R133-49.
[CROSSREF] [PUBMED]
4. Palmer BF, Clegg DJ. The sexual dimorphism of obesity. Mol Cell Endocrinol 2015;402:113-9.
[CROSSREF] [PUBMED]
5. Accili D, Arden KC. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 2004;117:421-6.
[CROSSREF] [PUBMED]
6. Karger S, Weidinger C, Krause K, Sheu SY, Aigner T, Gimm O, et al. FOXO3a: a novel player in thyroid carcinogenesis? Endocr Relat Cancer 2009;16:189-99.
[CROSSREF] [PUBMED]
7. Barthel A, Schmoll D, Unterman TG. FoxO proteins in insulin action and metabolism. Trends Endocrinol Metab 2005;16:183-9.
[CROSSREF] [PUBMED]
8. Biggs WH 3rd, Meisenhelder J, Hunter T, Cavenee WK, Arden KC. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc Natl Acad Sci U S A 1999;96:7421-6.
[CROSSREF] [PUBMED] [PMC]
9. Kawamori D, Kaneto H, Nakatani Y, Matsuoka TA, Matsuhisa M, Hori M, et al. The forkhead transcription factor Foxo1 bridges the JNK pathway and the transcription factor PDX-1 through its intracellular translocation. J Biol Chem 2006;281:1091-8.
[CROSSREF] [PUBMED]
10. Martinez SC, Tanabe K, Cras-Meneur C, Abumrad NA, Bernal-Mizrachi E, Permutt MA. Inhibition of Foxo1 protects pancreatic islet beta-cells against fatty acid and endoplasmic reticulum stress-induced apoptosis. Diabetes 2008;57:846-59.
[CROSSREF] [PUBMED]
11. Van Der Heide LP, Hoekman MF, Smidt MP. The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem J 2004;380(Pt 2):297-309.
[CROSSREF] [PUBMED] [PMC]
12. Lehrke M, Lazar MA. The many faces of PPARgamma. Cell 2005;123:993-9.
[PUBMED]
13. Matsusue K, Kusakabe T, Noguchi T, Takiguchi S, Suzuki T, Yamano S, et al. Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27. Cell Metab 2008;7:302-11.
[PUBMED] [PMC]
14. Wierzbicki M, Chabowski A, Zendzian-Piotrowska M, Gorski J. Differential effects of in vivo PPAR alpha and gamma activation on fatty acid transport proteins expression and lipid content in rat liver. J Physiol Pharmacol 2009;60:99-106.
15. Kim DH, Zhang T, Lee S, Calabuig-Navarro V, Yamauchi J, Piccirillo A, et al. FoxO6 integrates insulin signaling with MTP for regulating VLDL production in the liver. Endocrinology 2014;155:1255-67.
[CROSSREF] [PUBMED] [PMC]
16. Bose SK, Kim H, Meyer K, Wolins N, Davidson NO, Ray R. Forkhead box transcription factor regulation and lipid accumulation by hepatitis C virus. J Virol 2014;88:4195-203.
[CROSSREF] [PUBMED] [PMC]
17. Polvani S, Tarocchi M, Galli A. PPARγ and oxidative stress: con(β) catenating NRF2 and FOXO. PPAR Res 2012 2012:641087.
[CROSSREF]
18. Kim DH, Lee B, Kim MJ, Park MH, An HJ, Lee EK, et al. Molecular mechanism of betaine on hepatic lipid metabolism: inhibition of forkhead box O1 (FoxO1) binding to peroxisome proliferator-activated receptor gamma (PPARγ). J Agric Food Chem 2016;64:6819-25.
[CROSSREF]
20. Lin HV, Accili D. Hormonal regulation of hepatic glucose production in health and disease. Cell Metab 2011;14:9-19.
[CROSSREF] [PUBMED] [PMC]
21. Rothmeier AS, Ruf W. Protease-activated receptor 2 signaling in inflammation. Semin Immunopathol 2012;34:133-49.
[CROSSREF] [PUBMED]
22. Badeanlou L, Furlan-Freguia C, Yang G, Ruf W, Samad F. Tissue factor-protease-activated receptor 2 signaling promotes diet-induced obesity and adipose inflammation. Nat Med 2011;17:1490-7.
[CROSSREF] [PUBMED] [PMC]
23. Srinivasan R, Ozhegov E, van den Berg YW, Aronow BJ, Franco RS, Palascak MB, et al. Splice variants of tissue factor promote monocyte-endothelial interactions by triggering the expression of cell adhesion molecules via integrin-mediated signaling. J Thromb Haemost 2011;9:2087-96.
[CROSSREF] [PUBMED] [PMC]
24. Park MK, Cho MK, Kang SA, Kim BY, Yu HS. The induction of the collagen capsule synthesis by Trichinella spiralis is closely related to protease-activated receptor 2. Vet Parasitol 2016;230:56-61.
[CROSSREF] [PUBMED]
25. Coudriet GM, Delmastro-Greenwood MM, Previte DM, Marre ML, O’Connor EC, Novak EA, et al. Treatment with a catalytic superoxide dismutase (SOD) mimetic improves liver steatosis, insulin sensitivity, and inflammation in obesity-induced type 2 diabetes. Antioxidants (Basel) 2017;6:85.
[CROSSREF] [PMC]
26. Guo S. Molecular basis of insulin resistance: the role of IRS and foxo1 in the control of diabetes mellitus and its complications. Drug Discov Today Dis Mech 2013;10:e27-33.
[CROSSREF] [PUBMED] [PMC]
27. Shearer AM, Rana R, Austin K, Baleja JD, Nguyen N, Bohm A, et al. Targeting liver fibrosis with a cell-penetrating protease-activated receptor-2 (PAR2) pepducin. J Biol Chem 2016;291:23188-98.
[CROSSREF] [PUBMED] [PMC]
28. Kim DH, Lee B, Lee J, Kim ME, Lee JS, Chung JH, et al. FoxO6-mediated IL-1β induces hepatic insulin resistance and age-related inflammation via the TF/PAR2 pathway in aging and diabetic mice. Redox Biol 2019;24:101184.
[CROSSREF] [PUBMED] [PMC]
29. Qu S, Altomonte J, Perdomo G, He J, Fan Y, Kamagate A, et al. Aberrant forkhead box O1 function is associated with impaired hepatic metabolism. Endocrinology 2006;147:5641-52.
[CROSSREF]
30. Cook JR, Matsumoto M, Banks AS, Kitamura T, Tsuchiya K, Accili D. A mutant allele encoding DNA binding-deficient FoxO1 differentially regulates hepatic glucose and lipid metabolism. Diabetes 2015;64:1951-65.
[CROSSREF] [PUBMED] [PMC]
31. Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and aging. Cell 2005;120:483-95.
[CROSSREF] [PUBMED]
32. Panici JA, Harper JM, Miller RA, Bartke A, Spong A, Masternak MM. Early life growth hormone treatment shortens longevity and decreases cellular stress resistance in long-lived mutant mice. FASEB J 2010;24:5073-9.
[CROSSREF] [PUBMED] [PMC]
33. Kops GJ, Dansen TB, Polderman PE, Saarloos I, Wirtz KW, Coffer PJ, et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 2002;419:316-21.
[CROSSREF] [PUBMED]
34. Ables GP. Update on PPARγ and nonalcoholic fatty liver disease. PPAR Res 2012 2012:912351.
[CROSSREF]
35. Matsumoto M, Han S, Kitamura T, Accili D. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J Clin Invest 2006;116:2464-72.
[CROSSREF]
36. Inoue M, Ohtake T, Motomura W, Takahashi N, Hosoki Y, Miyoshi S, et al. Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice. Biochem Biophys Res Commun 2005;336:215-22.
[PUBMED]
37. Matsusue K, Haluzik M, Lambert G, Yim SH, Gavrilova O, Ward JM, et al. Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J Clin Invest 2003;111:737-47.
[PUBMED] [PMC]
38. Yu S, Matsusue K, Kashireddy P, Cao WQ, Yeldandi V, Yeldandi AV, et al. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. J Biol Chem 2003;278:498-505.
[CROSSREF] [PUBMED]
39. Navab M, Gharavi N, Watson AD. Inflammation and metabolic disorders. Curr Opin Clin Nutr Metab Care 2008;11:459-64.
[CROSSREF] [PUBMED]
40. Galgani JE, Uauy RD, Aguirre CA, Diaz EO. Effect of the dietary fat quality on insulin sensitivity. Br J Nutr 2008;100:471-9.
[CROSSREF] [PUBMED]
41. Tereshina EV. Metabolic abnormalities as a basis for age-dependent diseases and aging? State of the art. Adv Gerontol 2009;22:129-38.
42. Noguerol J, Roustan PJ, N’Taye M, Delcombel L, Rolland C, Guiraud L, et al. Sexual dimorphism in PAR2-dependent regulation regulation of primitive colonic cells. Biol Sex Differ 2019;10:47.
43. Wang J, Chakrabarty S, Bui Q, Ruf W, Samad F. Hematopoietic tissue factor-protease-activated receptor 2 signaling promotes hepatic inflammation and contributes to pathways of gluconeogenesis and steatosis in obese mice. Am J Pathol 2015;185:524-35.
[CROSSREF] [PUBMED] [PMC]